Assessment of varicella vaccine effectiveness in Germany: A time-series approach

Epidemiology and Infection

Volumn 139, Issue 11, 2011, Pages 1710-1719

  Hohle M ^a,b   Siedler, A ^a   Bader, H M ^c   Ludwig, M ^d   Heininger, U ^e   Von Kries, R ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Ministry for Health   (Germany)

^d Kassenärztliche Vereinigung Schleswig Holstein ^*  (Germany)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

GP surveillance systems; infectious disease epidemiology; statistics; vaccines; varicella zoster

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; CHICKENPOX; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; GERMANY; HEALTH PROGRAM; HUMAN; INFECTION PREVENTION; LIMIT OF QUANTITATION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; SENTINEL SURVEILLANCE; TIME SERIES ANALYSIS; VACCINATION;

CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; GENERAL PRACTITIONERS; GERMANY; HUMANS; IMMUNITY, HERD; IMMUNIZATION SCHEDULE; INFANT; MULTIVARIATE ANALYSIS; SENTINEL SURVEILLANCE;

EID: 80053569695     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810002815     Document Type: Article

References (43)

1. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New England Journal of Medicine 2005; 352: 450-458. (Pubitemid 40175971)
2. Reynolds MA, et al. Epidemiology of varicella hospitalizations in the United States, 1995-2005. Journal of Infectious Diseases 2008; 197 (Suppl. 2): S120-126. (Pubitemid 351590158)
3. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114: 786-792. (Pubitemid 41529540)
4. Seward JF, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. Journal of the American Medical Association 2002; 287: 606-611. (Pubitemid 34252012)
5. Seward JF, Marin M, Vazquez M. Varicella vaccine effectiveness in the US vaccination program: a review. Journal of Infectious Diseases 2008; 197 (Suppl. 2): S82-89. (Pubitemid 351590152)
6. Kuter B, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatric Infectious Disease Journal 2004; 23: 132-137. (Pubitemid 38222785)
7. Gould PL, et al. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients - Arkansas, 2006. Pediatric Infectious Disease Journal 2009; 28: 678-681.
8. Nardone A, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25: 7866-7872. (Pubitemid 47588519)
9. Heininger U, Seward JF. Varicella. Lancet 2006; 368: 1365-1376.
10. Siedler A, Arndt U. The impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Eurosurveillance 2010; 15(13): pii=19530.
11. Halloran ME, Longini IM, Struchiner CJ. Design and Analysis of Vaccine Studies. New York: Springer, 2010.
12. Halloran ME, et al. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. American Journal of Epidemiology 1994; 140: 81-104. (Pubitemid 24205807)
13. Brisson M, et al. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine 2000; 18: 2775-2778. (Pubitemid 30254462)
14. Farrington CP. Estimation of vaccine effectiveness using the screening method. International Journal of Epidemiology 1993; 22: 742-746. (Pubitemid 23247580)
15. Anderson RM, Grenfell BT, May RM. Oscillatory fluctuations in the incidence of infectious disease and the impact of vaccination: time series analysis. Journal of Hygiene (London) 1984; 93: 587-608. (Pubitemid 15181021)
16. Grijalva CG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369: 1179-1186. (Pubitemid 46527876)
17. Antunes JL, et al. Effectiveness of influenza vaccination and its impact on health inequalities. International Journal of Epidemiology 2007; 36: 1319-1326. (Pubitemid 350239001)
18. Girard DZ. Intervention times series analysis of pertussis vaccination in England and Wales. Health Policy 2000; 54: 13-25.
19. Mullooly JP, et al. Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella. Vaccine 2004; 22: 1480-1485. (Pubitemid 38446925)
20. Kalies H, et al. Vaccination coverage in children can be estimated from health insurance data. BMC Public Health 2008; 8: 82.
21. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.
22. Halloran ME, Longini Jr. IM, Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiological Review 1999; 21: 73-88. (Pubitemid 29441986)
23. Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland: 1981 to 1998. Communicable Disease and Public Health 2000; 3: 282-287.
24. Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. Journal of Medical Virology 2003; 70 (Suppl. 1): S31-37. (Pubitemid 36368842)
25. Ferguson NM, Anderson RM, Garnett GP. Mass vaccination to control chickenpox: the influence of zoster. Proceedings of the National Academy of Sciences USA 1996; 93: 7231-7235. (Pubitemid 26243531)
26. Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: a mathematical model. Epidemiology and Infection 1992; 108: 495-511.
27. Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008; 122: E744-E751.
28. Quian J, et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005. Archives of Diseases in Childhood 2008; 93: 845-850.
29. Guris D, et al. Changing varicella epidemiology in active surveillance sites - United States, 1995-2005. Journal of Infectious Diseases 2008; 197 (Suppl. 2): S71-75. (Pubitemid 351590150)
30. Bayer O, et al. Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine 2007; 25: 6655-6660. (Pubitemid 47332733)
31. Chaves SS, et al. Loss of vaccine-induced immunity to varicella over time. New England Journal of Medicine 2007; 356: 1121-1129. (Pubitemid 46425596)
32. Spackova M, et al. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine 2010; 28: 686-691.
33. Clements DA, et al. Postlicensure study of varicella vaccine effectiveness in a day-care setting. Pediatric Infectious Disease Journal 1999; 18: 1047-1050.
34. Seward JF, et al. Contagiousness of varicella in vaccinated cases: a household contact study. Journal of the American Medical Association 2004; 292: 704-708. (Pubitemid 39062524)
35. Vazquez M, et al. Effectiveness over time of varicella vaccine. Journal of the American Medical Association 2004; 291: 851-855. (Pubitemid 38543773)
36. Anon. Vaccine coverage at school health examinations in Germany, 2007 [in German]. Epidemiologisches Bulletin 2009; 16: 143-145.
37. Bader HM, Ludwig M. Vaccine coverage from association of SHI physicians billing: regional determination of immunization from birth until the age of 24 months 2003-2007 in the state of Schleswig-Holstein/Northern Germany. In: Abstracts of the 1st National Vaccination Conference, 5-7 March 2009, pp. 22-23 (http://www. nationale-impfkonferenz.de/media/Abstractband-5-03- 09-.pdf), 2009.
38. Fahrmeir L, Tutz G. Multivariate Statistical Modelling Based on Generalized Linear Models, 2nd edn. New York: Springer, 2001.
39. Mebane WR, Sekhon JS. Robust estimation and outlier detection for overdispersed multinomial models of count data. American Journal of Political Science 2004; 48: 392-411. (Pubitemid 38516569)
40. Herzog SA, Paul M, Held L. Heterogeneity in vaccination rates explains the size and occurence of measles epidemics in German surveillance data. Epidemiology and Infection. Published online: 12 July 2010. doi:10.1017/ S0950268810001664.
41. McLean AR, Anderson RM. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiology and Infection 1988; 100: 419-442.
42. Goldman GS. The case against varicella vaccination. International Journal of Toxicology 2006; 25: 313-317.
43. Shumway RH, Stoffer DS. Time Series Analysis and its Applications. New York: Springer, 2000.